{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:04:28Z","timestamp":1793642668108,"version":"4.5.1"},"reference-count":33,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T00:00:00Z","timestamp":1239148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> The proportion of patients who respond to proton pump inhibitor (PPI) therapy is about 20% lower in those with non\u2010erosive reflux disease (NERD) than in those with erosive oesophagitis.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To assess efficacy and safety of dexlansoprazole MR, a PPI using Dual Delayed Release technology, in NERD patients.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> In this 4\u2010week, double\u2010blind, placebo\u2010controlled study, 947 NERD patients randomly received dexlansoprazole MR 30\u2003mg, 60\u2003mg or placebo once daily (QD). The percentages of 24\u2010h heartburn\u2010free days (primary) and nights without heartburn (secondary) were assessed from patients\u2019 daily diaries. Investigators also assessed symptoms. Patients completed validated quality of life and symptom severity questionnaires.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Dexlansoprazole MR provided significantly greater median percentages of 24\u2010h heartburn\u2010free days (54.9% and 50.0% for the 30\u2010 and 60\u2010mg doses vs. 17.5% for placebo, <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.00001) and nights without heartburn (80.8% and 76.9% vs. 51.7%, <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.00001 vs. placebo). Dexlansoprazole MR also reduced symptom severity. Quality of life improvements in patients receiving dexlansoprazole MR were consistent with clinical efficacy endpoints. Percentages of patients experiencing treatment\u2010emergent adverse events were similar among groups.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Dexlansoprazole MR 30 and 60\u2003mg were superior to placebo in providing 24\u2010h heartburn\u2010free days and nights in NERD patients. Treatment was well tolerated.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04013.x","type":"journal-article","created":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T06:46:30Z","timestamp":1239173190000},"page":"1261-1272","source":"Crossref","is-referenced-by-count":82,"title":["Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non\u2010erosive reflux disease"],"prefix":"10.1111","volume":"29","author":[{"given":"R.","family":"FASS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. D.","family":"CHEY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. F.","family":"ZAKKO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"ANDHIVAROTHAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. N.","family":"PALMER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"PEREZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. N.","family":"ATKINSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.051821"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02531.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03596.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(03)02011-X"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.21.2373"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05912.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.6.885"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00944.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01702.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00288-5"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016062508580"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00813.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00856.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03984.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802693883"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.44186000.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199802000-00004"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-3000-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01771.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011212"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1810"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.5.587"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323020-00001"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01745.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05769.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.08783.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00349-0"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03933.x"},{"key":"e_1_2_6_30_2","volume-title":"Esomeprazole Magnesium","author":"Nexium\u00ae","year":"2008"},{"key":"e_1_2_6_31_2","volume-title":"Rabeprazole Sodium","author":"Aciphex\u00ae","year":"2008"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41217.x"},{"key":"e_1_2_6_33_2","first-page":"1906","article-title":"Tegaserod treatment for dysmotility\u2010like functional dyspepsia: results of two randomized, controlled trials","volume":"103","author":"Vakil N","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920020-00008"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04013.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04013.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:04:04Z","timestamp":1697177044000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04013.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,21]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04013.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04013.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,21]]}}}